Traders Bet on IonQ Micron Anduril as Next US Government Stake Targets AZZ Q1 2026 Earnings EPS Beats Estimates by 886 as Stock Edges Lower Cyient Navigates Revenue Growth Hurdles and Margin Compression EARN Q1 2026 Earnings EPS Misses Estimates Shares Dip 279 APVO Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Reports No Revenue MAZE Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher MDAI Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges DFIN Q1 2026 Earnings EPS Beats Estimates by 567 as Stock Rises BATRK Q1 2026 Earnings Earnings Beat Estimates Despite Negative EPS CHCT Q1 2026 Earnings EPS Blowout Surprises by 449 as Revenue Details Remain Unclear